Status:
UNKNOWN
Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.
Lead Sponsor:
Instituto Nacional de Enfermedades Respiratorias
Conditions:
HIV
ART
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the effect of zinc gluconate and/or selenium yeast supplementation during six months on clinical (glucose, cholesterol, triglycerides, bone mineral density and bod...
Detailed Description
HIV-infected individuals on antiretroviral treatment have lowest risk of AIDS events and more life expectancy. However, antiretroviral treatment does not fully restore the immune system in all individ...
Eligibility Criteria
Inclusion
- HIV infected
- \>200 CD4+ cells/mL
- \>2 years under antiretroviral treatment
- \>2 years under virology control (HIV RNA \<40 copies/mL)
Exclusion
- Patients with opportunistic infection
- Patients taking vitamin-mineral supplements
- Patients with moderate or high cardiovascular risk (Framingham score higher than 10%) and cholesterol LDL \>190 mg/dL or triglycerides \>500 mg/dL.
- Patients with diabetes or hypertension diagnosis.
- Patients taking drugs for diabetes, hypertension, dyslipidemia or low bone mass density.
- Low adherence to supplementation.
Key Trial Info
Start Date :
September 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT03421314
Start Date
September 1 2016
End Date
January 1 2020
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Investigaciones en Enfermedades Infecciosas
Mexico City, Mexico City, Mexico, 14080